Cherry Joel

Avg. Two Year Performance

No purchase track record

89% Avg. Sale Return

38% Compound

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	--	--	--	--	--
Purchase Success Rate	--	--	--	--	--
Average Sale Return	4%	26%	55%	85%	89%
Sale Success Rate	3 of 5	4 of 5	5 of 5	5 of 5	5 of 5

Amyris, Inc.

Drugs » Biotechnology

President of R&D:

Holdings: 241.42K shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--